South Korea-US stock market struck again by fear of inflation…SK Basa reverses decline, rather than “tasang”
[금일 제약업계 주요기사] Celltrion antibody treatment’approved’… Bukwang Pharmaceutical “Corona 19 treatment, clinical phase 2 IND approval by the US FDA, etc.
“SK-developed corona vaccine, phase 3 clinical trial after securing interim results in the third quarter”